The $1M IPO bonus, decent pay and a nice equity stake to mark the upside: How does Mark McKenna's comp package stack up in the Nasdaq rush?

Mark McKenna raised a few eyebrows when he jumped from the CEO spot at Bausch sub Salix to take charge of a low-profile biotech …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

TRENDING NOW

The $1M IPO bonus, de­cent pay and a nice eq­ui­ty stake to mark the up­side: How does Mark McKen­na's comp pack­age stack up in the Nas­daq rush?